BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 31095738)

  • 1. From latency to overt bone metastasis in breast cancer: potential for treatment and prevention.
    Salvador F; Llorente A; Gomis RR
    J Pathol; 2019 Sep; 249(1):6-18. PubMed ID: 31095738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer.
    Quayle L; Ottewell PD; Holen I
    Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between cancer cells and bone microenvironment in bone metastasis.
    Yoneda T; Hiraga T
    Biochem Biophys Res Commun; 2005 Mar; 328(3):679-87. PubMed ID: 15694401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time to metastatic relapse and breast cancer cells dissemination in bone marrow at metastatic relapse.
    Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Rodrigues M; Diéras V; Mignot L; Sastre-Garau X; Poupon MF; Pierga JY
    Clin Exp Metastasis; 2008; 25(8):871-5. PubMed ID: 18989740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.
    Westbrook JA; Wood SL; Cairns DA; McMahon K; Gahlaut R; Thygesen H; Shires M; Roberts S; Marshall H; Oliva MR; Dunning MJ; Hanby AM; Selby PJ; Speirs V; Mavria G; Coleman RE; Brown JE
    J Pathol; 2019 Mar; 247(3):381-391. PubMed ID: 30426503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New therapeutic targets for cancer bone metastasis.
    Krzeszinski JY; Wan Y
    Trends Pharmacol Sci; 2015 Jun; 36(6):360-73. PubMed ID: 25962679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast Cancer Dormancy in Bone.
    Clements ME; Johnson RW
    Curr Osteoporos Rep; 2019 Oct; 17(5):353-361. PubMed ID: 31468498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The critical role of the ZNF217 oncogene in promoting breast cancer metastasis to the bone.
    Bellanger A; Donini CF; Vendrell JA; Lavaud J; Machuca-Gayet I; Ruel M; Vollaire J; Grisard E; Győrffy B; Bièche I; Peyruchaud O; Coll JL; Treilleux I; Maguer-Satta V; Josserand V; Cohen PA
    J Pathol; 2017 May; 242(1):73-89. PubMed ID: 28207159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Metastasis of Breast Cancer.
    Tahara RK; Brewer TM; Theriault RL; Ueno NT
    Adv Exp Med Biol; 2019; 1152():105-129. PubMed ID: 31456182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status in human breast cancer micrometastasis.
    Alix-Panabières C; Müller V; Pantel K
    Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
    Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
    J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells.
    Ogba N; Manning NG; Bliesner BS; Ambler SK; Haughian JM; Pinto MP; Jedlicka P; Joensuu K; Heikkilä P; Horwitz KB
    Breast Cancer Res; 2014 Dec; 16(6):489. PubMed ID: 25475897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil.
    Wang Y; Hu Y; Wang M; Wang M; Xu Y
    Curr Osteoporos Rep; 2024 Feb; 22(1):28-43. PubMed ID: 38206556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of bisphosphonates in the prevention of metastases in early-stage breast cancer.
    Coleman R
    Clin Breast Cancer; 2007 Jul; 7 Suppl 1():S29-35. PubMed ID: 17683651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Involvement of Jagged1 in Metastatic Progression of Human Breast Carcinomas.
    Bednarz-Knoll N; Efstathiou A; Gotzhein F; Wikman H; Mueller V; Kang Y; Pantel K
    Clin Chem; 2016 Feb; 62(2):378-86. PubMed ID: 26721293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel model of dormancy for bone metastatic breast cancer cells.
    Marlow R; Honeth G; Lombardi S; Cariati M; Hessey S; Pipili A; Mariotti V; Buchupalli B; Foster K; Bonnet D; Grigoriadis A; Rameshwar P; Purushotham A; Tutt A; Dontu G
    Cancer Res; 2013 Dec; 73(23):6886-99. PubMed ID: 24145351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer bone metastases: pathogenesis and therapeutic targets.
    Brook N; Brook E; Dharmarajan A; Dass CR; Chan A
    Int J Biochem Cell Biol; 2018 Mar; 96():63-78. PubMed ID: 29309917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling the breast cancer bone metastatic niche in complex three-dimensional cocultures.
    Marlow R; Dontu G
    Methods Mol Biol; 2015; 1293():213-20. PubMed ID: 26040690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.
    Bado I; Gugala Z; Fuqua SAW; Zhang XH
    Oncogene; 2017 Aug; 36(32):4527-4537. PubMed ID: 28368409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.